Health-care companies rose as the biotech sub-sector gathered momentum.
Moderna shares rose by more than 9%, and were headed for their largest monthly gain on record, due to enthusiasm about its cancer vaccine.
Jazz Pharmaceuticals shares rose after the Food and Drug Administration approved the drug maker's product candidate, Ziihera, to treat a form of stomach cancer.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires






